NasdaqCM - Delayed Quote USD

Bellevue Life Sciences Acquisition Corp. (BLAC)

Compare
11.40
+0.06
+(0.53%)
At close: January 3 at 4:00:00 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-1,964.53
-818.77
-4.24
-0.46
Investing Cash Flow
53,312.31
-33,829.82
--
--
Financing Cash Flow
-51,393.49
34,539.50
123.98
-57.44
End Cash Position
12.24
15.42
124.50
4.76
Income Tax Paid Supplemental Data
478.21
16.25
--
--
Issuance of Capital Stock
--
63,970.00
--
--
Issuance of Debt
1,578.00
--
800.00
100.00
Repayment of Debt
--
-1,200.00
--
--
Repurchase of Capital Stock
-53,041.49
-35,995.73
--
--
Free Cash Flow
-1,964.53
-818.77
-4.24
-0.46
12/31/2021 - 3/21/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers